Radiation Treatment Plan Evaluation Learning Tool Pilot Project
- Conditions
- Radiation Oncology
- Registration Number
- NCT06115811
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.
- Detailed Description
This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.
Stud procedures include screening for eligibility and completion of surveys and oncology examinations.
Participation is expected to last about 6-8 weeks.
It is expected about 20 radiation oncology resident physicians will participate in the study.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 20
- The pilot program will be open to radiation oncology resident physicians that are in their PGY-2, PGY-3, or PGY-4 year.
- All residents must have completed a breast cancer-specific radiation oncology rotation at least 3 months prior to enrollment in the pilot program in order to be eligible.
-The study will not include any special populations.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Objective Examination Score Up to 8 weeks Analyzed with a paired samples t-test.
- Secondary Outcome Measures
Name Time Method Oncology Resident Confidence Rate Week 1 - 8 Scored using Likert scales and analyzed with non-parametric tests.
Oncology Resident Perceived Competence Rate Week 1 - 8 Scored using Likert scales and analyzed with non-parametric tests.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Massachusetts General Hospital Cancer Center
🇺🇸Boston, Massachusetts, United States
Massachusetts General Hospital Cancer Center🇺🇸Boston, Massachusetts, United StatesRachel Jimenez, MDContact617-726-8651RBJIMENEZ@PARTNERS.ORG